Annual Retained Earnings
-$477.90 M
-$101.17 M-26.85%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual retained earnings is -$477.90 million, with the most recent change of -$101.17 million (-26.85%) on December 31, 2023.
- During the last 3 years, XFOR annual retained earnings has fallen by -$283.73 million (-146.12%).
- XFOR annual retained earnings is now -1249.52% below its all-time high of -$35.41 million, reached on December 31, 2015.
Performance
XFOR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$475.53 M
-$36.70 M-8.36%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly retained earnings is -$475.53 million, with the most recent change of -$36.70 million (-8.36%) on September 30, 2024.
- Over the past year, XFOR quarterly retained earnings has dropped by -$36.70 million (-8.36%).
- XFOR quarterly retained earnings is now -714.44% below its all-time high of -$58.39 million, reached on December 31, 2016.
Performance
XFOR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
XFOR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.9% | -8.4% |
| 3 y3 years | -146.1% | -8.4% |
| 5 y5 years | -253.3% | -292.3% |
XFOR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.0% | at low | -68.1% | +10.2% |
| 5 y | 5-year | -261.9% | at low | -260.1% | +10.2% |
| alltime | all time | -1249.5% | at low | -714.4% | +10.2% |
X4 Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$475.53 M(+8.4%) |
| Jun 2024 | - | -$438.84 M(-17.1%) |
| Mar 2024 | - | -$529.67 M(+10.8%) |
| Dec 2023 | -$477.90 M(+26.9%) | -$477.90 M(+4.2%) |
| Sep 2023 | - | -$458.77 M(+0.5%) |
| Jun 2023 | - | -$456.47 M(+13.9%) |
| Mar 2023 | - | -$400.76 M(+6.4%) |
| Dec 2022 | -$376.74 M(+33.2%) | -$376.74 M(+8.4%) |
| Sep 2022 | - | -$347.63 M(+6.6%) |
| Jun 2022 | - | -$326.05 M(+7.0%) |
| Mar 2022 | - | -$304.84 M(+7.8%) |
| Dec 2021 | -$282.87 M(+45.7%) | -$282.87 M(+12.0%) |
| Sep 2021 | - | -$252.66 M(+8.7%) |
| Jun 2021 | - | -$232.49 M(+9.2%) |
| Mar 2021 | - | -$212.85 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -$194.18 M(+47.1%) | -$194.18 M(+10.5%) |
| Sep 2020 | - | -$175.78 M(+11.0%) |
| Jun 2020 | - | -$158.33 M(+10.6%) |
| Mar 2020 | - | -$143.18 M(+8.4%) |
| Dec 2019 | -$132.04 M(-2.4%) | -$132.04 M(+8.9%) |
| Sep 2019 | - | -$121.21 M(+17.1%) |
| Jun 2019 | - | -$103.49 M(+14.9%) |
| Mar 2019 | - | -$90.11 M(-33.4%) |
| Dec 2018 | -$135.29 M(+46.6%) | -$135.29 M(+7.4%) |
| Sep 2018 | - | -$125.93 M(+9.5%) |
| Jun 2018 | - | -$115.03 M(+11.8%) |
| Mar 2018 | - | -$102.89 M(+11.5%) |
| Dec 2017 | -$92.27 M(+58.0%) | -$92.27 M(+13.8%) |
| Sep 2017 | - | -$81.08 M(+38.9%) |
| Dec 2016 | -$58.39 M(+64.9%) | -$58.39 M |
| Dec 2015 | -$35.41 M | - |
FAQ
- What is X4 Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual retained earnings year-on-year change?
- What is X4 Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly retained earnings year-on-year change?
What is X4 Pharmaceuticals annual retained earnings?
The current annual retained earnings of XFOR is -$477.90 M
What is the all time high annual retained earnings for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual retained earnings is -$35.41 M
What is X4 Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, XFOR annual retained earnings has changed by -$101.17 M (-26.85%)
What is X4 Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of XFOR is -$475.53 M
What is the all time high quarterly retained earnings for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly retained earnings is -$58.39 M
What is X4 Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, XFOR quarterly retained earnings has changed by -$36.70 M (-8.36%)